Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma

M Vaglini, F Bozzetti, G Viganotti

    Tumori
    |October 31, 1978
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews 12 mesothelioma cases to develop a treatment program for this aggressive cancer. The findings aim to improve outcomes for patients with this rapidly fatal tumor.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer.

    Clinical nutrition ESPEN·2022
    Same author

    Does nutrition for cancer patients feed the tumour? A clinical perspective.

    Critical reviews in oncology/hematology·2020
    Same author

    Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    ESPEN expert group recommendations for action against cancer-related malnutrition.

    Clinical nutrition (Edinburgh, Scotland)·2017
    Same author

    Defining malnutrition: A plea to rethink.

    Clinical nutrition (Edinburgh, Scotland)·2016
    Same author

    European Society of Coloproctology consensus on the surgical management of intestinal failure in adults.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
    Same journal

    End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

    Tumori·2026
    Same journal

    Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

    Tumori·2026
    Same journal

    Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

    Tumori·2026
    Same journal

    Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

    Tumori·2026
    Same journal

    Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

    Tumori·2026
    Same journal

    Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

    Tumori·2026
    See all related articles

    Area of Science:

    • Oncology
    • Thoracic Surgery
    • Pathology

    Background:

    • Mesothelioma is a rare but aggressive malignancy arising from the mesothelial lining of body cavities.
    • The tumor is characterized by rapid growth and a poor prognosis, posing significant treatment challenges.

    Purpose of the Study:

    • To review existing literature and present a series of 12 mesothelioma cases.
    • To formulate a comprehensive treatment program for malignant mesothelioma.

    Main Methods:

    • Case series review of 12 patients diagnosed with mesothelioma.
    • Literature data analysis to identify current treatment strategies and outcomes.

    Main Results:

    • The study presents data from 12 mesothelioma cases.

    Related Experiment Videos

  • Literature review highlights the aggressive nature and poor survival rates associated with mesothelioma.

    • Conclusions:

    • A structured treatment program is proposed for malignant mesothelioma.
    • Further research and standardized treatment protocols are needed to improve patient survival.